Journal
INTERNATIONAL ORTHOPAEDICS
Volume 38, Issue 4, Pages 881-889Publisher
SPRINGER
DOI: 10.1007/s00264-013-2163-3
Keywords
Biodegradable magnesium; Orthopaedics; Immature skeleton; Growth; Biocompatibility
Categories
Funding
- Laura Bassi Center of Expertise BRIC (Bioresorbable Implants for Children)
- Laura Bassi Center of Expertise BRIC (FFG - Austria)
- Staub/Kaiser Foundation, Switzerland
Ask authors/readers for more resources
In recent decades operative fracture treatment using elastic stable intramedullary nails (ESINs) has mainly taken precedence over conservative alternatives in children. The development of biodegradable materials that could be used for ESINs would be a further step towards treatment improvement. Due to its mechanical and elastic properties, magnesium seems to be an ideal material for biodegradable implant application. The aim of this study was therefore to investigate the cellular reaction to biodegradable magnesium implants in vitro. Primary human growth plate chondrocytes and MG63 osteoblasts were used for this study. Viability and metabolic activity in response to the eluate of a rapidly and a slower degrading magnesium alloy were investigated. Furthermore, changes in gene expression were assessed and live cell imaging was performed. A superior performance of the slower degrading WZ21 alloy's eluate was detected regarding cell viability and metabolic activity, cell proliferation and morphology. However, the ZX50 alloy's eluate induced a favourable up-regulation of osteogenic markers in MG63 osteoblasts. This study showed that magnesium alloys for use in biodegradable implant application are well tolerated in both osteoblasts and growth plate chondrocytes respectively.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available